Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

The goal of this observational study is to evaluate the feasibility and acceptability of a newly developed digital education and self-management program for people with fibrotic interstitial lung diseases (FILD) during inpatient pulmonary rehabilitation and outpatient interstitial lung disease (ILD) care. The study also explores whether participation in the program is associated with changes in health-related outcomes.

The main questions this study aims to answer are:

* Is the digital education and self-management program acceptable, useful, and practical for patients with FILD? * Is it feasible to recruit and retain patients and to collect outcome data for a future larger effectiveness study? * Do patients who participate in the program show differences in health-related outcomes compared with patients treated before the program was implemented?

Patients who consent to participate during the implementation phase will be offered access to the digital education and self-management program. Their outcomes will be compared with those of a historical cohort of patients who received usual care before the program was introduced.

Participants will:

* Use a web-based digital education and self-management program with multiple e-learning modules tailored to individual needs and preferences * Access the program via smartphone, tablet, or computer during inpatient rehabilitation or outpatient care * Discuss questions related to the program content with healthcare professionals during routine rehabilitation sessions or clinic visits * Complete questionnaires about their experience with the program and their health-related outcomes

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of a FILD as major indication for pulmonary rehabilitation (for Berner Reha Zentrum only)

Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB_2016-01524) and agreed to further use of data for further research purpose (for Inselspital only)

Age ≥ 18 years

Written informed consent

Disqualifiers

Cognitive inability or insufficient knowledge of project language (German) to follow informed consent or study procedures

Sarcoidosis

Trial design

Design model

Single group

Treatments tested in this trial

  • Blended patient education and self-management programme

    Behavioral

    The program consists of multiple web-based e-learning modules covering core and optional topics relevant to lung fibrosis. Modules are suggested based on individual symptoms and self-management needs, but all content is accessible to all users. The program can be accessed via smartphone, tablet, or computer using a web link. It is intended solely for education and well-being support and is not used for diagnosis, monitoring, treatment, or prognosis of disease. In inpatient rehabilitation, patients may use the program flexibly during their stay, with support from therapists as needed, and can discuss content during routine therapy sessions. In outpatient care, patients receive access during an ILD clinic visit and can discuss content during follow-up appointments, supported by reminders to encourage use.

Treatment groups

80 Participants
are divided into 1 treatment group
Group A: Intervention groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Intervention feasibility outcomes - Acceptance

Acceptability of Intervention Measure (AIM): 4-item questioniare measuring the acceptability of an intervention on a 5-likert scale (completely disagree to completely agree).

Time frame
3-6 months follow-up
2

Intervention feasibility outcomes - Appropriateness

Intervention Appropriateness Measure (IAM): 4-item questioniare measuring the appropriation of an intervention on a 5-likert scale (completely disagree to completely agree).

Time frame
3-6 months follow-up
3

Intervention feasibility outcomes - Feasibiilty

Feasibility of Intervention Measure (FIM): 4-item questioniare measuring the acceptability of an intervention on a f-likert scale (completely disagree to completely agree).

Time frame
3-6 months follow-up
4

Intervention feasibility outcomes - Compliance

percent of attended/performed educational modules.

Time frame
3-6 months follow-up

Secondary outcomes

1

Study feasibility outcomes - Recruitment success

Recruitment success: Time to assess the targeted the 50 patients for the feasibility study.

Time frame
3-6 months
2

Study feasibility outcomes - Retention

Number of recruited patients that successfully completed the study (pre- and post-assessment)

Time frame
3-6 months
3

Study feasibility outcomes - Data collection:

Percentage of missing data in outcome assessments.

Time frame
3-6 months
4

Health related outcomes - self efficacy

Change in self-efficacy from t0 to t1 and t2, assessed with the Pulmonary Rehabilitation Adapted Index of Self-Efficacy

Time frame
3- 6 months follow-up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Insel Gruppe AG, University Hospital Bern

Lead sponsor

University of Zurich

Collaborator

ZHAW School of Health Professions, Institute of Physiotherapy

Collaborator